Industry: Healthcare
Published Date: November-2024
Format: PPT*, PDF, EXCEL
Delivery Timelines: Contact Sales
Number of Pages: 172
Report ID: PMRREP28777
The global orthopedic surgical robots market is estimated to increase from US$ 2.2 Bn in 2024 to US$ 4.6 Bn by 2031. The market is projected to record a CAGR of 10% during the forecast period from 2024 to 2031. Growth will likely be pushed by increasing demand for minimally invasive surgeries across the globe.
Around 50 to 60% of all surgical procedures performed worldwide are now minimally invasive, especially in disciplines like general surgery, cardiology, gynecology, and orthopedics. Growing demand for less intrusive procedures and technological improvements are predicted to propel the global field of minimally invasive surgery from US$ 29 Bn in 2020 to over US$ 65 Bn by 2027.
More than 80% of surgeries in specialties like laparoscopic cholecystectomy (gallbladder removal) and colorectal surgery are utilizing minimally invasive surgery (MIS) techniques. The U.S. is among the leaders in the adoption of MIS. Particularly common is robotic-assisted surgery, urology, gynecology, and general surgery, all use systems like Da Vinci. Nowadays, robots assist in about 20 to 30% of all procedures performed in these domains.
Key Highlights of the Market
Market Attributes |
Key Insights |
Orthopedic Surgical Robots Market Size (2024E) |
US$ 2.2 Bn |
Projected Market Value (2031F) |
US$ 4.6 Bn |
Global Market Growth Rate (CAGR 2024 to 2031) |
10% |
Historical Market Growth Rate (CAGR 2019 to 2023) |
8.4% |
North America is likely to generate an orthopedic surgical robots market share of 29.9% in 2024. This is mainly due to its robust healthcare infrastructure, novel technological ecosystem, and strong focus on innovation. The region benefits from the early adoption of cutting-edge medical technologies, including robotic systems designed for precision and minimally invasive procedures.
High healthcare expenditure, particularly in the U.S., enables hospitals and surgical centers to invest in unique robotic platforms, such as Stryker's Mako and Zimmer Biomet’s ROSA systems. These are widely regarded for their efficiency in joint replacement surgeries. Moreover, increasing prevalence of orthopedic conditions like osteoarthritis, coupled with a rapidly aging population, drives demand for robotic-assisted surgeries that improve outcomes and reduce recovery times. For instance,
Category |
Market Share in 2024 |
Application - Spine Surgery |
27.7% |
Spine surgery is poised to be the most prominent contributor to the orthopedic surgical robots market growth in 2024. It will likely be driven by the rising prevalence of spinal disorders and high demand for precision in complex procedures. Conditions such as herniated discs, degenerative disc disease, and scoliosis are increasingly common due to aging populations and sedentary lifestyles, necessitating unique surgical interventions. For example,
Robotic systems are revolutionizing spine surgeries by offering unparalleled precision, reducing the risk of nerve damage, and ensuring optimal implant placement. These systems integrate novel imaging and navigation technologies, enabling surgeons to perform minimally invasive procedures with high accuracy and reduced recovery times.
The integration of Artificial Intelligence (AI) in orthopedic surgical robots is transforming the landscape of precision surgery, particularly in knee and hip replacements. AI-driven systems leverage large datasets to analyze patient-specific anatomical details and historical surgical outcomes. These help in enabling surgeons to predict potential challenges and optimize surgical plans.
Novel predictive analytics tools assess variables such as bone density, joint alignment, and implant positioning. These help enhance surgical precision and minimize complications like implant loosening or misalignment.
AI algorithms intraoperatively provide real-time guidance by continuously analyzing data from sensors and imaging systems. This dynamic feedback ensures accurate adjustments during the procedure, reducing the risk of errors and enhancing implant longevity. Additionally, AI enables robots to learn from previous surgeries, refining their algorithms to improve outcomes over time.
The orthopedic surgical robots market witnessed a considerable CAGR of 8.4% in the historical period from 2019 to 2023. It was driven by developments in robotic technology and a rising preference for minimally invasive procedures. Historically, the product saw steady adoption as early robotic systems demonstrated their ability to improve surgical precision. These also helped reduce recovery times, particularly in joint replacement and spinal surgeries.
The orthopedic surgical robots industry is poised to continue its upward trajectory, with a CAGR projected in double digits for the next ten years. The forecast growth is underpinned by the integration of artificial intelligence, augmented reality, and real-time analytics. These are enhancing the functionality and appeal of these systems.
As healthcare systems in emerging economies modernize, demand for orthopedic surgical robots is set to surge, especially in ambulatory surgery centers and outpatient settings. With ongoing developments in robotics and a growing focus on patient-centric care, the market is set to redefine standards in orthopedic surgery globally.
Prevalence of Osteoarthritis and Musculoskeletal Disorders to Push Demand
Increasing prevalence of osteoarthritis and musculoskeletal disorders is a significant driver of the orthopedic surgical robot industry. Osteoarthritis, the most common joint disorder, affects millions worldwide, particularly among aging populations.
Coupled with this factor, musculoskeletal disorders such as rheumatoid arthritis, fractures, and ligament injuries are also rising. These are being driven by factors like sedentary lifestyles, obesity, and sports-related injuries. These conditions often require surgical interventions, such as joint replacements or reconstructions, to restore functionality and alleviate pain.
Integration of AI and Machine Learning to Augment Demand
Orthopedic surgical robots are now smarter, more adaptable, and much more efficient due to the combination of Artificial Intelligence (AI) and Machine Learning (ML). Better patient outcomes and shorter recovery periods are the results of these technologies' ability to facilitate data analysis, real-time decision-making, and increased precision during surgical procedures.
AI-enabled robots give real-time input during surgery, modifying their motions in response to unforeseen obstacles like shifting tissue density or patient movement. This guarantees consistent outcomes and lowers errors. For example, robotic systems with Machine Learning (ML) capabilities can improve their methods over time by learning from previous procedures.
High Initial Cost to be a Barrier for Small-scale Practices
One influential factor that is likely to affect the performance of the orthopedic surgical robots market is the high initial cost of these systems. This creates a significant barrier to their widespread adoption, particularly in small-scale healthcare institutions or emerging markets. These systems often require an investment of several hundred thousand to millions of dollars, which includes robotic hardware, software, and specialized tools.
For various healthcare providers, particularly those in regions with limited budgets or small-scale practices, the upfront cost is a considerable financial burden. In several cases, this cost can divert funds from other critical needs, such as staffing, medical supplies, or infrastructure improvements.
The expense often extends beyond just the purchase price, as there are ongoing costs associated with system maintenance, updates, and training. Various hospitals must also factor in the costs of ensuring their surgical teams are trained to operate these unique machines.
For institutions in lower-income countries, these barriers are even more pronounced, as healthcare funding is often constrained. The prioritization of robotic systems can be a low concern compared to more immediate healthcare needs. As a result, the high cost of orthopedic robotic systems significantly limits their accessibility, especially in non-affluent regions. It is anticipated to slow down the adoption of this technology despite its potential advantages in improving surgical outcomes.
Long Setup Times May Limit Adoption across Busy Operating Rooms
Despite the impressive precision and accuracy that orthopedic robotic systems offer, their setup and calibration times can present significant challenges to surgical workflows. These robotic systems often require extensive preparation before use, including configuring the hardware, loading software updates, and calibrating the robot for each specific procedure.
The process of adjusting the robot to align with patient anatomy, as well as confirming system readiness, can take around 30 minutes or longer, depending on the complexity of the procedure. In high-pressure environments, such as busy operating rooms with tight schedules, this extended setup time can cause delays, affecting not only the surgery but also the utilization of the operating room.
Hospitals may experience a reduction in the number of surgeries performed per day, affecting throughput and productivity. Surgeons may also face delays due to the learning curve associated with using the robotic systems, further extending preparation times. In addition to impacting operating room efficiency, these delays can frustrate surgical teams and increase healthcare costs.
Surging Demand from Outpatient Surgery Centers to Create Opportunities
The rise of outpatient surgery centers is reshaping the healthcare landscape, driven by cost efficiency, convenience, and short recovery times. This trend creates significant opportunities for orthopedic surgical robots designed specifically for ambulatory care settings. These centers often face constraints such as limited space, tight budgets, and the need for high patient throughput.
Robotic systems tailored to these needs can provide a competitive advantage, allowing facilities to offer cutting-edge technology without key infrastructural investments. Additionally, these robots streamline workflows, enabling precision in surgeries like knee and hip arthroplasties while reducing intraoperative time and enhancing patient outcomes.
Outpatient centers cater to a growing demographic of younger and middle-aged patients seeking elective orthopedic procedures. Hence, there is an increasing demand for minimally invasive solutions that ensure quick return to daily activities. Robotic systems can optimize these procedures by improving accuracy, minimizing tissue damage, and reducing recovery periods, making them ideal for outpatient environments.
Coupled with developments in telemonitoring and AI integration, robotic systems can support remote postoperative care, further enhancing their appeal in outpatient care settings. This synergy between outpatient care and robotic technology positions manufacturers to tap into a rapidly expanding market with tailored, accessible, and scalable solutions.
The global robotic surgery in orthopedics industry is marked by intense competition. Key players are vying to enhance technological innovation, extend their market reach, and improve affordability.
Dominant companies like Stryker Corporation, Zimmer Biomet, and Smith and Nephew lead the market with robust portfolios of robotic systems. They are offering unique capabilities such as AI integration, real-time imaging, and haptic feedback. These firms also invest heavily in research and development to maintain technological superiority and differentiate themselves from competitors.
Recent Industry Developments
Attributes |
Details |
Forecast Period |
2024 to 2031 |
Historical Data Available for |
2019 to 2023 |
Market Analysis |
US$ Billion for Value |
Key Country Covered |
|
Key Market Segments Covered |
|
Key Companies Profiled |
|
Report Coverage |
|
Customization and Pricing |
Available upon request |
By Application
By End User
By Region
To know more about delivery timeline for this report Contact Sales
The market is set to increase from US$ 2.2 Bn in 2024 to US$ 4.6 Bn by 2031.
The industry is set to be propelled by developments in robotic technology, and increasing prevalence of orthopedic disorders.
The market is projected to record a CAGR of 10% from 2024 to 2031.
Rising application across outpatient surgery centers is set to be a key opportunity.
Stryker Mako Robotic-Arm Assisted Technology is a commonly used robot.